首页> 外文OA文献 >Constitutive coupling of a naturally occurring human alpha1a-adrenergic receptor genetic variant to EGFR transactivation pathway
【2h】

Constitutive coupling of a naturally occurring human alpha1a-adrenergic receptor genetic variant to EGFR transactivation pathway

机译:自然存在的人α1a-肾上腺素能受体基因变异与EGFR反式激活途径的本构偶联

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We previously identified a naturally occurring human SNP, G247R, in the third intracellular loop of the α1a-adrenergic receptor (α1a-247R) and demonstrated that constitutive expression of α1a-247R results in twofold increased cell proliferation compared with WT. In the present study we elucidate molecular mechanisms and signal transduction pathways responsible for increased cell proliferation unique to α1a-247R, but not α1a-WT, α1b, or α1dAR subtypes. We show that elevated levels of matrix metalloproteinase-7 (MMP7) and a disintegrin and metalloproteinase-12 (ADAM12) in α1a-247R–expressing cells are responsible for EGF receptor (EGFR) transactivation, downstream ERK activation, and increased cell proliferation; this pathway is confirmed using MMP, EGFR, and ERK inhibitors. We demonstrate that EGFR transactivation and downstream ERK activation depends on increased shedding of heparin-binding EGF. Finally, we demonstrate that knockdown of MMP7 or β-arrestin1 by shRNAs results in attenuation of proliferation of cells expressing α1a-247R. Importantly, accelerated cell proliferation triggered by the α1a-247R is serum- and agonist-independent, providing unique evidence for constitutive active coupling to the β-arrestin1/MMP/EGFR transactivation pathway by any G protein-coupled receptor. These findings raise the possibility of a previously unexplored mechanism for sympathetically mediated human hypertension triggered by a naturally occurring human genetic variant.
机译:我们先前在α1a-肾上腺素能受体(α1a-247R)的第三个细胞内环中鉴定了天然存在的人SNP,G247R,并证明与WT相比,α1a-247R的组成型表达导致细胞增殖增加了两倍。在本研究中,我们阐明了导致α1a-247R特有的细胞增殖增加的分子机制和信号转导途径,但没有阐明α1a-WT,α1b或α1dAR亚型。我们显示,表达α1a-247R的细胞中基质金属蛋白酶7(MMP7)和整合素和金属蛋白酶12(ADAM12)水平升高是EGF受体(EGFR)激活,下游ERK激活和细胞增殖增加的原因;使用MMP,EGFR和ERK抑制剂可以证实该途径。我们证明,EGFR反式激活和下游ERK激活取决于肝素结合EGF脱落的增加。最后,我们证明了shRNA敲低MMP7或β-arrestin1会导致表达α1a-247R的细胞增殖减弱。重要的是,由α1a-247R触发的加速细胞增殖与血清和激动剂无关,这为通过任何G蛋白偶联受体与β-arrestin1/ MMP / EGFR反式激活途径组成性主动偶联提供了独特的证据。这些发现增加了由自然发生的人类遗传变异触发的,由交感神经介导的人类高血压先前未曾探索的机制的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号